Filing Details

Accession Number:
0001209191-21-017282
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 18:45:24
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 18:45:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Albireo Pharma Inc. ALBO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1687436 Jan Mattsson C/O Albireo Pharma Inc.
10 Post Office Square, Suite 1000
Boston MA 02109
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 39,330 $1.00 69,044 No 4 M Direct
Common Stock Disposition 2021-03-01 15,300 $37.45 53,744 No 4 S Direct
Common Stock Disposition 2021-03-02 12,351 $36.07 41,393 No 4 S Direct
Common Stock Disposition 2021-03-02 612 $36.54 40,781 No 4 S Direct
Common Stock Disposition 2021-03-02 2,807 $37.15 37,974 No 4 S Direct
Common Stock Disposition 2021-03-03 400 $36.20 37,574 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-03-01 39,330 $0.00 39,300 $1.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-03-18 No 4 M Direct
Footnotes
  1. Represents 63,544 shares of common stock and 5,500 restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. Represents 48,244 shares of common stock and 5,500 restricted stock units.
  4. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  5. Represents 35,893 shares of common stock and 5,500 restricted stock units.
  6. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.52 to $36.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  7. Represents 35,281 shares of common stock and 5,500 restricted stock units.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  9. Represents 32,474 shares of common stock and 5,500 restricted stock units.
  10. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  11. Represents 32,074 shares of common stock and 5,500 restricted stock units.
  12. This option is fully vested.